Overview

Clinical Study Of Eplerenone In Japanese Patients With Chronic Heart Failure

Status:
Completed
Trial end date:
2015-09-01
Target enrollment:
Participant gender:
Summary
A study to compare the efficacy and safety of eplerenone in Japanese chronic heart failure patients with placebo.
Phase:
Phase 3
Details
Lead Sponsor:
Pfizer
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Treatments:
Eplerenone
Spironolactone